FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
208845NDAPACIRA PHARMS INC001ZILRETTAFOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR32MG/VIALTRIAMCINOLONE ACETONIDE2017-10-06PrescriptionYes
022496NDAPACIRA PHARMS INC001EXPARELINJECTABLE, LIPOSOMAL;INJECTION133MG/10ML (13.3MG/ML)BUPIVACAINE2011-10-28PrescriptionYes
002EXPARELINJECTABLE, LIPOSOMAL;INJECTION266MG/20ML (13.3MG/ML)BUPIVACAINE2011-10-28PrescriptionYes
021671NDAPACIRA PHARMS INC001DEPODURINJECTABLE, LIPOSOMAL;EPIDURAL10MG/ML (10MG/ML)MORPHINE SULFATE2004-05-18DiscontinuedNo
002DEPODURINJECTABLE, LIPOSOMAL;EPIDURAL15MG/1.5ML (10MG/ML)MORPHINE SULFATE2004-05-18DiscontinuedNo
003DEPODURINJECTABLE, LIPOSOMAL;EPIDURAL20MG/2ML (10MG/ML)MORPHINE SULFATE2004-05-18DiscontinuedNo
021041NDAPACIRA PHARMS INC001DEPOCYTINJECTABLE, LIPOSOMAL;INJECTION10MG/MLCYTARABINE1999-04-01DiscontinuedNo